Provider
QP52-19 Pharmacy Benefit Exclusion for Cimzia, Elzonris, Gamifant, Kalbitor, Khapzory, leucovorin calcium, Nuzyra and Panzyga
Program effective Date: Jun 12, 2019
Search Results
Displaying 2851 - 2860 of 3654 results
Provider
QP48-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Somatostatin Analogs
Program effective Date: Jun 12, 2019
Provider
QP47-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary transthyretin-mediated (hATTR) Amyloidosis Neuropathy
Program effective Date: Jun 12, 2019
Provider
QP57-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization Criteria: tafamidis
Program effective Date: Jun 12, 2019
Provider
QP53-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Neurotrophic Keratitis
Program effective Date: Jun 12, 2019
Provider
QP59-19 eviCore Group Number List to be Removed
Program effective Date: Jun 12, 2019
Provider
QP51-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Firdapse
Program effective Date: Jun 12, 2019
Provider
QP62-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Interleukin 5 (IL-5) Inhibitors
Program effective Date: Jun 26, 2019
Provider
QP60-19 2019 Blue Cross Basic Seminars
Program effective Date: Jun 26, 2019
Provider
QP61-19 Availity Portal Authorization Frequently Asked Questions
Program effective Date: Jun 26, 2019